[Application and clinical significance of TCGA molecular classification in endometrial cancer].

Zhao, L Y; Dai, Y B; Li, L W; Wang, Z Q; Wang, J L

Zhao, L Y; Dai, Y B; Li, L W; Wang, Z Q; Wang, J L.

Afiliação

Zhao LY; Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing 100044, China.
Dai YB; Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing 100044, China.
Li LW; Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing 100044, China.
Wang ZQ; Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing 100044, China.
Wang JL; Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing 100044, China.

Zhonghua Fu Chan Ke Za Zhi ; 56(10): 697-704, 2021 Oct 25.

Article em Zh | MEDLINE | ID: mdl-34823319

Assuntos

Neoplasias do Endométrio; Biomarcadores Tumorais/genética; DNA Polimerase II/genética; Neoplasias do Endométrio/genética; Feminino; Humanos; Instabilidade de Microssatélites; Mutação; Prognóstico

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Endométrio Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: Zh Revista: Zhonghua Fu Chan Ke Za Zhi Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google